Oragenics Inc (OGEN) Annual Balance Sheets

Annual · GAAP · USD millions
Access OGEN quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Oragenics Inc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent4.40
Short-term Investments, Total4.00
Cash & Short-term Investments8.00
Interest Receivable NO0.05
Prepaid Expense And Other Assets Current1.61
Total Current Assets10.07
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets10.07
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.56
Notes Payable, Current NO0.23
Other Liabilities, Current0.00
Total Current Liabilities1.79
Total Long-term Debt0.00
Other liabilities, Noncurrent1.79
Operating Lease Liability Current0.00
Operating Lease Liability Noncurrent0.00
Total Liabilities1.79
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock234.91
Retained Earnings / Accumulated Deficit-226.63
Other Equity0.00
Common Stockholder's Equity8.28
Preferred Stockholder's Equity0.00
Total Stockholder's Equity8.28
Liabilities & Stockholder's Equity10.07
4 historic quarters locked

Sign in to unlock the full Oragenics Inc balance sheet history.

About Oragenics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 16, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-010282

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.